Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC

Clinical trial NCT01640808 · COMPLETED

Trial details

NCT number: NCT01640808
Sponsor: Kowa Company, Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatic Neoplasm Malignant Recurrent

Start date: 2012-04-01
Primary completion: 2016-10-01
Enrollment: 616

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.